Anson Funds Management LP Cyteir Therapeutics, Inc. Transaction History

Anson Funds Management LP

  • $607 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$2.84 - $3.13 $646,645 - $712,675
-227,692 Reduced 17.2%
1,096,422 $3.33 Million
Q3 2023

Nov 13, 2023
BUY
$2.71 - $2.84 $467,344 - $489,763
172,452 Added 14.97%
1,324,114 $3.76 Million
Q2 2023

Aug 14, 2023
BUY
$1.74 - $2.6 $2 Million - $2.99 Million
1,151,662 New
1,151,662 $2.99 Million

Others Institutions Holding CYT

# of Institutions
6
Shares Held
6.18M
Call Options Held
0
Put Options Held
0
View Full List

About Cyteir Therapeutics, Inc.

CYT Quotes by TradingView
  • Ticker CYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,413,400
  • Market Cap $107M
  • Description
  • Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...
More about CYT
Track This Portfolio

Track Anson Funds Management LP Portfolio

Follow Anson Funds Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Anson Funds Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email